Guillain-Barre Syndrome Associated with Peginterferon Alfa-2a: A Case Report

被引：0

作者：

Koca, Irfan ^{[1
]}

Altindag, Ozlem ^{[1
]}

Madenci, Ercan ^{[1
]}

Ucar, Mehmet ^{[2
]}

Celik, Ahmet ^{[1
]}

机构：

[1] Gaziantep Univ, Tip Fak, Fiziksel Tip Rehabil Klin, Gaziantep, Turkey

[2] Bozok Univ, Tip Fak, Fiziksel Tip Rehabil Klin, Yozgat, Turkey

来源：

TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION | 2014年 / 60卷 / 01期

关键词：

Guillain-Barre Syndrome; interferon alpha-2 alpha; chronic hepatitis C; CHRONIC HEPATITIS-C;

D O I：

10.5152/tftrd.2014.86658

中图分类号：

R49 [康复医学];

学科分类号：

100215 ;

摘要：

Polyethylene glycol-interferon alpha (PEG-IFN alpha), used in the treatment of chronic hepatitis C, has the potential risk for serious side effects. Among the most frequent side effects are symptoms similar to flu, depression, nervousness, and bone marrow suppression. Serious neurological side effects that have an influence on the peripheral nerves are rarely reported. In this article, a 58-year-old woman with the clinical findings of Guillain-Barre syndrome in the sixth week of PEG-IFa-2a treatment is analyzed and discussed.

引用

页码：65 / 68

页数：4

共 12 条

[1]

Avila-Funes JA, 2002, REV INVEST CLIN, V54, P357

[2] Diagnosis, Management, and Treatment of Hepatitis C: An Update [J].

Ghany, Marc G. ;

Strader, Doris B. ;

Thomas, David L. ;

Seeff, Leonard B. .

HEPATOLOGY, 2009, 49 (04) :1335-1374

[3] Early electrodiagnostic findings in Guillain-Barre syndrome [J].

Gordon, PH ;

Wilbourn, AJ .

ARCHIVES OF NEUROLOGY, 2001, 58 (06) :913-917

[4] Guillain-Barre syndrome following influenza vaccination [J].

Haber, P ;

DeStefano, F ;

Angulo, FJ ;

Iskander, J ;

Shadomy, SV ;

Weintraub, E ;

Chen, RT .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (20) :2478-2481

[5] Recovery patterns and long term prognosis for axonal Guillain-Barre syndrome [J].

Hiraga, A ;

Mori, M ;

Ogawara, K ;

Kojima, S ;

Kanesaka, T ;

Misawa, S ;

Hattori, T ;

Kuwabara, S .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (05) :719-722

[6] Practice parameter: Immunotherapy for Guillain-Barre syndrome - Report of the quality standards subcommittee of the American Academy of Neurology [J].

Hughes, RAC ;

Wijdicks, EFM ;

Barohn, R ;

Benson, E ;

Cornblath, DR ;

Hahn, AF ;

Meythaler, JM ;

Miller, RG ;

Sladky, JT ;

Stevens, JC .

NEUROLOGY, 2003, 61 (06) :736-740

[7] Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection [J].

Khiani, Vijay ;

Kelly, Thomas ;

Shibli, Adeel ;

Jensen, Donald ;

Mohanty, Smruti R. .

WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (02) :318-321

[8] Rehabilitation outcomes of patients who have developed Guillain-Barre syndrome [J].

Meythaler, JM ;

DeVivo, MJ .

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1997, 76 (05) :411-419

[9] Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: A case report [J].

Niazi, Mumtaz A. ;

Azhar, Ashaur ;

Tufail, Kashif ;

Feyssa, Eyob L. ;

Penny, Stephen F. ;

McGregory, Marlene ;

Araya, Victor ;

Ortiz, Jorge A. .

WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (04) :162-166

[10]

Ogawara K, 2000, ANN NEUROL, V48, P624, DOI 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO

← 1 2 →